Nesiritide, a recombinant form of human B-type natriuretic peptide, is an intravenous treatment that is US Food and Drug Administration (FDA)-approved for patients with acutely decompensated heart ...

How can a drug that is associated with higher rates of both renal dysfunction and death than placebo — and that costs 50 times as much as standard therapies and for which there are no meaningful data ...

Contacted by heartwire for comment on their publications, both Cuffe and Young noted that these two papers represent a step forward in the treatment of decompensated heart failure, not just because of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. New medications to manage HF are few and far between. So ...

Please provide your email address to receive an email when new articles are posted on . Outpatient nesiritide infusions did not provide a clinical benefit superior to intensive outpatient management ...

Review the side-effects of Nesiritide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Discover comprehensive details about Nesiritide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Adding low-dose dopamine or low-dose nesiritide to diuretic therapy did not preserve renal function or enhance urine output in patients with acute heart failure and renal dysfunction, despite previous ...

A new study by researchers from Loma Linda University Medical Center shows initial use of the intravenous drug nesiritide may lead to significantly reduced length of hospital stay for patients with ...

The largest study ever done on heart failure has found that a promising drug is not dangerous, as had been feared. But it also does not seem to be particularly effective. Medical experts say the ...

NEW YORK, July 27 (Praxis Press) Intravenous infusion of nesiritide, a brain (B-type) natriuretic peptide, has beneficial hemodynamic effects in patients with decompensated congestive heart failure ...